MannKind Corp $7.12

down -0.07


21/8/2014 10:50 AM  |  NASDAQ : MNKD  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get MNKD Trend Analysis - it has underperformed the S&P 500 by 2%

Partner Headlines

  1. Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza

    GuruFocus
  2. There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will ...

    GuruFocus
  3. Zynga Goes Out To Pasture; Kinder Morgan Combines Companies

    Benzinga
  4. Dean Foods Dips On Q2 Results; Kinder Morgan Shares Spike Higher

    Benzinga
  5. Markets Open Higher; Priceline Issues Downbeat Profit Forecast

    Benzinga
  6. Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising

    IBD
  7. Morning Market Movers

    Benzinga
  8. MannKind Up 20% On Diabetes Deal With Sanofi

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  11. Sanofi and MannKind Announce Global Licensing Agreement for Afrezza (insulin ...

    Benzinga
  12. What This Upcoming Monday Means For MannKind Shareholders

    GuruFocus
  13. Morning Market Movers

    Benzinga
  14. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes ...

    GuruFocus
  15. Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts ...

    GuruFocus
  16. Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin ...

    GuruFocus
  17. A Look at Mannkind Corporation's True Value

    GuruFocus
  18. Morning Market Losers

    Benzinga
  19. Benzinga's Top #PreMarket Losers

    Benzinga
  20. UPDATE: MLV & Co. Downgrades MannKind On Fair Valuation

    Benzinga
  21. Markets Little Changed As The Quarter Comes To An End

    Benzinga
  22. General Motors Issues More Recalls, Reach 27 Million Autos Recalled In ...

    Benzinga
  23. MannKind Jumps On FDA Approval; Rayonier Shares Slide

    Benzinga
  24. RBC Looks For Post-Approval Data On MannKind

    Benzinga
  25. Markets Edge Higher; PPG To Acquire Comex For $2.3 Billion

    Benzinga
  26. Benzinga's Volume Movers

    Benzinga
  27. Stocks Hitting 52-Week Highs

    Benzinga
  28. Morning Market Movers

    Benzinga
  29. MannKind Shares See #PreMarket Spike Following FDA Approval

    Benzinga
  30. Benzinga's Top #PreMarket Gainers

    Benzinga
  31. Stocks To Watch For June 30, 2014

    Benzinga
  32. Regarding Afrezza, FDA Statement:

    Benzinga
  33. 6 Stocks That May Be Worth Buying Right Now

    Benzinga
  34. UPDATE: Piper Jaffray Upgrades MannKind After 'Busted' Call For Afrezza

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. UPDATE: Brinson Patrick Initiates Coverage on MannKind

    Benzinga
  37. Benzinga's Top Initiations

    Benzinga
  38. Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered ...

    Benzinga
  39. Mid-Day Market Update: Dow Tumbles Over 100 Points; Intel Shares Rise Following ...

    Benzinga
  40. MannKind: FDA Delays Afrezza Decision by Three Months

    FoxBusiness
  41. Mid-Morning Market Update: Markets Drop; Mallinckrodt To Acquire Questcor ...

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Benzinga's Top #PreMarket Losers

    Benzinga
  44. MannKind Announces FDA Extends PDUFA Date for AFREZZA By 3 Months

    Benzinga
  45. Morning Market Movers

    Benzinga
  46. Benzinga's Top #PreMarket Gainers

    Benzinga
  47. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares ...

    Benzinga
  48. Piper Jaffray Not Convinced MannKind's Afreeza Will Be Commercial Success ...

    Benzinga
  49. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike ...

    Benzinga
  50. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street ...

    Benzinga
Trading Center